You are here

Lexston Life Sciences Corp.

Lexston Life Sciences Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LEXT
CSE Index: 
Currency: 

Lexston Life Sciences Corp. (“Lexston”) is a Canadian biotechnology company providing cannabis testing and research services.  Lexston is also in the process of securing licensing under the exemptions prescribed by section 56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of its services into the psychedelic industry with an initial focus on the detection and quantification of psychedelic molecules in the lab and point of care. Lexston intends to develop and validate methods for standardized manufacturing of plant derived psychedelics in support of burgeoning trials in the field of mental health and wellness.

You are here

Lexston Life Sciences Corp. (LEXT)

SEDAR Information

Company Info

Address
1150, 789 W. Pender St.
Vancouver, BC V6C 1H2
Canada
Phone
604-928-8913
Fax
604-628-0129
Email
admin@lexston.net
Website
http://www.lexston.ca
Listing date
Friday, June 25, 2021
Transfer Agent
Odyssey Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
57,033,634
Reserved for Issuance: 
18,231,595

Company Officers

Harinder Bains, Director
Jagdip Bal, President & CEO
Philippe Henry, Director & Chief Science Officer
Jatinder Manhas, Director
Dimitrios Mitrakos, Corporate Secretary & CFO
Graeme Staley, Director

Bulletins

23/06/2021

2021-0631– New Listing - Lexston Life Sciences Corp. (LEXT)

Le 23 juin/June 2021

The common shares of Lexston Life Sciences Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News